Is Elon's Empire Crumbling?

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health

TOM MURPHY
May 01, 2025

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1. Zepbound will be excluded.

This could complicate access to a drug that many patients cannot afford to pay for on their own.

The formulary is maintained by CVS Health's pharmacy benefits management business, which runs prescription drug coverage for millions of people. Employers and insurers -- who pay most of the prescription bill -- use the formulary to decide which drugs get coverage.

They can customize their coverage plans to include Zepbound. But CVS Health spokesman David Whitrap said most employers wind up using the standard formulary because of the discounts negotiated for them.

Patients taking Zepbound will be able to switch to Wegovy if the Lilly drug is excluded from their coverage, Whitrap said.

CVS Health also said Thursday that it will start selling Wegovy at a discounted price of about $500 monthly at thousands of drugstores for people without coverage. Novo had announced its new lower price last month.

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity due to the amount of weight people lose while taking the injections. Coverage of these drugs has been patchy due to in part to their cost and the wide swath of patients who could take them.

Shortages of the drugs also have made access challenging, but those have eased recently. That allows pharmacy benefit managers to pit the products against each other to negotiate lower prices in exchange for inclusion on a formulary.

Lilly may have to make some price cuts to restore formulary access, said Daniel Barasa, who follows the company for Gabelli Funds. But he said he thinks big employers will still include both treatments on their lists of covered drugs, leaving the choice on what to use up to patients and doctors.

Lilly said late last year that a head-to-head study of the two drugs showed that Zepbound helped patients drop more pounds.

Zepbound has emerged as one of Lilly's top sellers. Its sales jumped to $2.3 billion in the recently completed first quarter. That's up from $517 million a year ago, during the drug's first full quarter on the market.

Lilly shares shed more than $90 in value, falling nearly 11% to $804.06 Thursday afternoon. Broader indexes, meanwhile, rose slightly.

Continue Reading...

Popular

The Stock Ticker Notable Investors Are Holding - Ad

They may not be trading on public markets, but Pacaso just reserved the ticker PCSO. Co-founded by the man who took Zillow from seed to IPO, Pacaso brings co-ownership to a $1.3T market. They've earned $110M+ in gross profits already. Well-known firms like Maveron even invested.

Trump Says He's 'Not Troubled' By Musk's Alleged Drug Use During Campaign: Report

Trump denies knowing about Musk's alleged drug use during 2024 campaign, says he is unbothered by the claims.

Democrats Face Generational Reckoning as Calls for Younger Leaders Grow: 'We Have a Geriatric Problem'

Democrats confront internal pressure to replace aging leaders with younger voices amid growing concerns over succession and relevance.

Putting Your Name on This List Could Hand You $1,270 on Friday - Ad

URGENT: On Tuesday, a simple set of instructions will be sent out to an elite group of investors. The folks in this group will have the opportunity to place a 10-minute trade that could double their money by Friday. Consider this your invitation to join them. The next trade is just days away.

The UK seeks to send a message to Moscow as it outlines higher defense spending

LONDON (AP) — The U.K. is about to see the biggest increase in defense spending since the end of the Cold War as it seeks to send "a message to Moscow," the British defense secretary said Sunday.

A Historic Gold Announcement Is About to Rock Wall Street - Ad

The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.

The euro is about to get a new member, Bulgaria. What's the eurozone and how do countries join?

FRANKFURT, Germany (AP) — European Union officials gave the green light Wednesday for of the euro currency union,, a key EU project aimed at deepening the ties between member countries.

Maverick Trader Reveals 97% Accurate System - Ad

This man's simple strategy makes money in any market...With a 97% accuracy at hitting winners over the past 8 years!

Russian captain denies manslaughter in North Sea collision, faces UK trial in January

LONDON (AP) — The Russian captain of a cargo ship that in the North Sea pleaded not guilty to the manslaughter of one of his crew at a U.K. court hearing on Friday.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Congressman Buys Up To $850K In Bitcoin In 2025: Late Disclosure, Close Trump Ties Wave Red Flags

A congressman has disclosed buying Bitcoin (CRYPTO: BTC) on four occasions in 2025, with some of the trades happening past the 45-day window, adding to the recent

Marjorie Taylor Greene Says She's 'Adamantly Opposed' To Trump's 'Big Beautiful' Bill Over This AI Provision: 'I Would Have Voted NO If I Had Known This Was In There'

Rep. Marjorie Taylor Greene is threatening to oppose Trump's spending bill over a provision banning state AI regulation, calling it a violation of states' rights and warning it could derail the legislation in the narrowly divided House.

This Trade Spit Out an Average of $185 a Day -- Like Clockwork - Ad

Forget cryptos, pot stocks, and other "shiny object" investments. Instead, you could collect an average of $185 every day of the year with this "boring" trade strategy Forbes magazine says is "like finding money in the street."

Global Gold Supply To Grow 1% In 2025, Report Shows

Global gold supply is expected to grow by 1% in 2025, according to Metal Focus. The precious metals consultancy is expecting this growth from fresh gains in mine production.

The Next Palantir? Does This Under $5 AI Stock Have The Potential To Rise And Shine

This micro-cap AI stock is being increasingly touted as the next Palantir Technologies Inc. (NASDAQ: PLTR), but some analysts disagree with this framing.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

What's Going On With MasterCard Shares Today?

Mastercard inc. (NYSE: MA) shares are trading lower Friday after a report revealed that major retailers like Walmart and Amazon are exploring the creation of their own stablecoins.

Shoppers are wary of digital shelf labels, but a study found they don't lead to price surges

Digital price labels, which are rapidly replacing paper shelf tags at U.S. supermarkets, haven’t led to , according to a new study that examined five years' worth of prices at one grocery chain.

IRA & 401(K) Savers Are Scrambling To Get In - Ad

Hollywood elites think this is the moment you betray Trump. But they're wrong. His IRS is letting Americans use a little-known, 100% tax-free loophole to shield IRA, 401(k), and pension savings through this economic reset. Learn how to activate it with just 2 words.

Supreme Court won't hear challenge to Maryland assault weapons ban

WASHINGTON (AP) — declined on Monday to hear a challenge to a state ban on assault weapons, semiautomatic rifles that are popular among gun owners and have also been used in multiple mass shootings.

US appeals court refuses to overturn Biden approval of Alaska's Willow oil project

JUNEAU, Alaska (AP) — A federal appeals court panel on Friday refused to overturn the approval of the on Alaska’s petroleum-rich North Slope.

Former Zillow Execs Target $1.3T Market - Ad

One co-founded Zillow. The other sold his company to Zillow for $120M. Now they're transforming a $1.3T market via co-ownership. Pacaso's already earned $110M+ in gross profit and reserved the Nasdaq ticker PCSO.

Warren Buffett Makes Over $2.2 Million A Day From This Stock

Warren Buffett's Berkshire Hathaway is set to earn $816 million in Coca-Cola dividends in 2025.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Trump Family's Crypto 'Conflicts Of Interest' Are Coming In The Way Of Law Meant To Regulate Digital Assets, Says Gregory Meeks

The involvement of President Donald Trump’s family in the cryptocurrency industry was creating problems in the progression of a bill designed to regulate the sector, a senior Democratic legislator said on Wednesday.

The Stock Ticker Notable Investors Are Holding - Ad

They may not be trading on public markets, but Pacaso just reserved the ticker PCSO. Co-founded by the man who took Zillow from seed to IPO, Pacaso brings co-ownership to a $1.3T market. They've earned $110M+ in gross profits already. Well-known firms like Maveron even invested.

Amazon Launches New Agentic AI Group To Boost Robotics, Enhance User Interactions

Amazon launches a new team within its consumer R&D division to focus on agentic artificial intelligence.

Qualcomm Stock Is Rising Monday: What's Going On?

QUALCOMM Inc (NASDAQ:QCOM) shares are trading higher Monday after the company announced it reached an agreement to acquire Alphawave Semi for $2.4 billion.

Putting Your Name on This List Could Hand You $1,270 on Friday - Ad

URGENT: On Tuesday, a simple set of instructions will be sent out to an elite group of investors. The folks in this group will have the opportunity to place a 10-minute trade that could double their money by Friday. Consider this your invitation to join them. The next trade is just days away.

Nebius Group Stock Is Ripping Higher Monday: What's Going On?

Nebius Group N.V. (NASDAQ:NBIS) shares are rising Monday. The stock may be getting a boost after the company announced the expansion of its global AI infrastructure footprint with a U.K. deployment.

A Historic Gold Announcement Is About to Rock Wall Street - Ad

The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.

Asian shares gain as investors keep an eye on China-US trade talks

Asian shares were mostly higher on Tuesday as investors kept an eye on that might help stave off a recession.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright priceactionea.net
Privacy Policy | Terms of Service